Chromosome 18 Clinical Research Center

Study acronym: Chromosome18
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv19
  2. Site contacts updated at 2 of 2 sitesv18
  3. Re-verified, no change to tracked fieldsv17
  4. Collaborators expanded, about 6 wordsv16
  5. Enrollment target: 1000 to 4000v15
Show 13 earlier versionsHide 13 earlier versions
  1. Primary and study completion dates: Dec 2025 to Dec 2040v14
  2. Study sites: 1 to 2v13
  3. 3 versions Re-verified since Sep 26, 2016, no change to tracked fieldsv10-v12
  4. Publications: 19 to 25v9
  5. Site contact updated
    • Collaborators shortened, about 2 words
    v8
  6. Enrollment target: 180 to 1000
    • Primary and study completion dates: Dec 2025
    • Collaborators: 2 to 1
    v7
  7. Collaborators revised (2)
    • Study description expanded, about 1 word
    v6
  8. Re-verified, no change to tracked fieldsv5
  9. Site contact updated
    • Collaborators: 3 to 2
    v4
  10. Re-verified, no change to tracked fieldsv3
  11. Interventions: Audiological and ear, nose and throat examination (Procedure), Behavior and neuropsychometric evaluations (Procedure), Dental evaluation… to Audiological and ear, nose and throat examination (Procedure), Behavior and neuropsychometric evaluations (Procedure), Dental evaluation…
    • Study description shortened, about 19 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our vision, that of the researchers at the University of Texas Health Science Center at San Antonio, is that every person with a chromosome 18 abnormality will have an autonomous and healthy life. Our mission is to provide families affected by chromosome 18 abnormalities with comprehensive medical and educational information. Our goals are to provide definitive medical and education resources for the families of individuals with chromosome 18 abnormalities; perform and facilitate groundbreaking clinical and basic research relating to the syndromes of chromosome 18; and to provide treatments to help these individuals overcome the effects of their chromosome abnormality.
Trial Details
NCT Number NCT00227253
Lead Sponsor The University of Texas Health Science Center at San Antonio
Collaborators: National Center for Research Resources (NCRR)
Conditions
(from sponsor)		 Chromosome Aberrations, Growth Hormone Deficiency, Hypomyelination
Related terms Chromosome Aberrations, Dwarfism, Pituitary
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov